sunitinib msn 37,5 mg
pharmadox healthcare limited - malta - sunitinibum - caps. - 37,5mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
sunitinib msn 50 mg
pharmadox healthcare limited - malta - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
irbesartan aurobindo 150 mg
apl swift services (malta) limited - malta - irbesartanum - compr. - 150mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
irbesartan aurobindo 300 mg
apl swift services (malta) limited - malta - irbesartanum - compr. - 300mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
meropenem accord 1 g
accord healthcare limited - marea britanie - meropenemum - pulb. pt. sol. inj./perf. - 1g - alte antibiotice betalactamice carbapeneme
meropenem accord 500 mg
accord healthcare limited - marea britanie - meropenemum - pulb. pt. sol. inj./perf. - 500mg - alte antibiotice betalactamice carbapeneme
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - agenți antineoplazici - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
nilide 100 mg comprimate filmate
cadila pharmaceuticals limited - nimesulidum - comprimate filmate - 100 mg
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
drytec 2,5 - 100 gbq
ge healthcare limited - marea britanie - tc 99 m - pertechnetat - generator de radionuclizi - 2,5-100gbq - tiroida preparate pentru radiodiagnostic la nivelul tiroidei, varia